PREDQ (Predictive Technology Group) Return-on-Tangible-Asset: -131.01% (As of Mar. 2021)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Predictive Technology Group Return-on-Tangible-Asset?

Predictive Technology Group PREDQ -90.00% Return-on-Tangible-Asset is -131.01% as of Mar. 2021.

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Predictive Technology Group's annualized Net Income for the quarter that ended in Mar. 2021 was $-29.55 Mil. Predictive Technology Group's average total tangible assets for the quarter that ended in Mar. 2021 was $22.55 Mil. Therefore, Predictive Technology Group's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2021 was -131.01%.

The historical rank and industry rank for Predictive Technology Group's Return-on-Tangible-Asset or its related term are showing as below:

PREDQ's Return-on-Tangible-Asset is not ranked *
in the Biotechnology industry.
Industry Median: -35.76
* Ranked among companies with meaningful Return-on-Tangible-Asset only.

Predictive Technology Group  (OTCPK:PREDQ) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Predictive Technology Group Return-on-Tangible-Asset Related Terms


Predictive Technology Group Return-on-Tangible-Asset Historical Data

* Premium members only.

The historical data trend for Predictive Technology Group's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Predictive Technology Group Return-on-Tangible-Asset Chart

Predictive Technology Group Annual Data
Trend Aug06 Aug07 Jun16 Jun17 Jun18 Jun19 Jun20
Return-on-Tangible-Asset
Get a 7-Day Free Trial -200.70 -32.62 -14.58 -23.62 -181.34

Predictive Technology Group Quarterly Data
Nov07 Feb08 May08 Jun16 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -118.37 -426.12 -232.03 -113.48 -131.01

PREDQ vs GLMD, RCAR, CKPT: Return-on-Tangible-Asset Comparison

For the Biotechnology subindustry, Predictive Technology Group's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Predictive Technology Group Return-on-Tangible-Asset vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Predictive Technology Group's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Predictive Technology Group's Return-on-Tangible-Asset falls into.



Predictive Technology Group Return-on-Tangible-Asset Calculation

Predictive Technology Group's annualized Return-on-Tangible-Asset for the fiscal year that ended in Jun. 2020 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Jun. 2020 )  (A: Jun. 2019 )(A: Jun. 2020 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Jun. 2020 )  (A: Jun. 2019 )(A: Jun. 2020 )
=-85.769/( (67.69+26.905)/ 2 )
=-85.769/47.2975
=-181.34 %

Predictive Technology Group's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2021 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2021 )  (Q: Dec. 2020 )(Q: Mar. 2021 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2021 )  (Q: Dec. 2020 )(Q: Mar. 2021 )
=-29.548/( (23.691+21.416)/ 2 )
=-29.548/22.5535
=-131.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2021) net income data.

What does a Return-on-Tangible-Asset of -131.01% mean?
Predictive Technology Group (PREDQ) has a Return-on-Tangible-Asset of -131.01% as of Mar. 2021. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Predictive Technology Group and its competitors.
Is Predictive Technology Group's Return-on-Tangible-Asset too high?
Predictive Technology Group's current Return-on-Tangible-Asset is -131.01%.
How does Predictive Technology Group's Return-on-Tangible-Asset compare to GLMD and RCAR?
Predictive Technology Group's Return-on-Tangible-Asset of -131.01% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Biotechnology company?
A good Return-on-Tangible-Asset depends on the Biotechnology industry context. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Predictive Technology Group and its competitors. Predictive Technology Group's current Return-on-Tangible-Asset is -131.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Predictive Technology Group stock overvalued right now?
Predictive Technology Group (PREDQ) has a current Return-on-Tangible-Asset of -131.01%. The current Return-on-Tangible-Asset is -131.01%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Predictive Technology Group (PREDQ), the current Return-on-Tangible-Asset is -131.01% as of Mar. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Predictive Technology Group Business Description

Address 2735 Parleys Way, Suite 205, Salt Lake City, UT, USA, 84109
Predictive Technology Group Inc (PRx) is a biotechnology company. It develops, commercializes, acquires and invests in technologies engaged in novel molecular diagnostic and therapeutic products in healthcare. The HCT/P segment offers minimally manipulated tissue products intended for homologous use, prepared utilizing proprietary extraction methods that reduce the loss of important scaffolding, growth factors and cytokines. The company's Diagnostics and Therapeutics segment uses data analytics for disease identification and subsequent therapeutic intervention through novel gene-based diagnostics, and companion therapeutics. It generates most of its revenues from HCT/Ps segment.